MBP 3.23% 3.0¢ metabolic pharmaceuticals limited

metabolic, signs of life

  1. 374 Posts.
    Metabolic has broken out of its recent trading range. Plenty of trades but, overall, small volume. This has been one of those situations where sellers gradually drop out over time due to inactive trading and the sell line has large gaps.

    Still, we are at a point now where MBP should be expecting some clinical trial results on its anti-obesity fragment of growth hormone. Actually, I would have expected this move earlier as results were touted to be available befoire Christmas.

    If results are good, I would expect a run to at least 90 cents. Longer term, I think this one has very good prospects.
watchlist Created with Sketch. Add MBP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.